San Antonio, TEXAS1 Active Studies

Parkinsons Disease Clinical Trials in San Antonio, TEXAS

Find 1 actively recruiting parkinsons disease clinical trials in San Antonio, TEXAS. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
94
Enrolling

Recruiting Parkinsons Disease Studies in San Antonio

About Parkinsons Disease Clinical Trials in San Antonio

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 1 parkinsons disease clinical trials recruiting participants in San Antonio, TEXAS. These studies are seeking a combined 94 participants. Research is being sponsored by The University of Texas Health Science Center at San Antonio. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in San Antonio — FAQ

Are there parkinsons disease clinical trials in San Antonio?

Yes, there are 1 parkinsons disease clinical trials currently recruiting in San Antonio, TEXAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Antonio?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Antonio research site will contact you about next steps.

Are clinical trials in San Antonio free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Antonio studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 1 active trials in San Antonio are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated March 2, 2026 from ClinicalTrials.gov